You are here

Industry weighs radical shake-up of European drug pricing

Wholesale adoption of the concept of drug pricing based on clinical results is proposed
Saturday, June 11, 2016 - 05:50

PRICING MATTERS: Mr Jimenez, the current president of Efpia, supports the pricing concept.


THE pharmaceutical industry is considering a radical shift in the way it prices drugs in Europe so companies are rewarded for the clinical benefit of treatments rather than the number of pills sold, according to an internal report.

The high price of drugs is straining Europe

Market voices on:

Pair your daily business read with the perfect cup of espresso.

Subscribe to The Business Times today to receive your very own Nespresso Inissia coffee machine worth $188.

Find out more at

Powered by GET.comGetCom